January 10, 2022 - Oregon State University (OSU) researchers have identified two cannabinoid compounds that may be used to prevent and treat infection from the COVID-19 virus. These two compounds, cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA), abundant in hemp and many hemp extracts, act as cell entry inhibitors which bond to the spike proteins of SARS-CoV-2, preventing entry into a cell. Current vaccines and antibody therapies target and bind to the same spike proteins, suggesting that cannabinoids can be used to create effective treatments.
“Our data show CBDA and CBGA are effective against the two variants we looked at, and we hope that trend will extend to other existing and future variants” said lead researcher Richard van Breemen of Oregon State’s Global Hemp Innovation Center, College of Pharmacy, and Linus Pauling Institute.
Read more at Oregon State University